Dawn of Community Pharmacovigilance-A Scope and Opportunity in India

Background

Pharmacovigilance plays a crucial role in safeguarding public health by detecting, assessing, and preventing Adverse Drug Reactions (ADRs) and related drug problems. Despite the establishment of the Pharmacovigilance Programme of India (PvPI), ADR underreporting remains a critical challenge, particularly in rural and underserved regions.

Objectives

This review introduces the concept of Community Pharmacovigilance® (CP) as a proactive, community-based approach aimed at expanding pharmacovigilance activities into the community at large.

Materials and Methods

CP advocates the integration of ADR monitoring into the routine duties of community-level healthcare workers, including ASHA, ANM, MPHW, and medical students, through the Family Adoption Program (FAP). These stakeholders, through regular interactions with families, identify ADRs, educate beneficiaries on safe medication practices, and strengthen ADR reporting mechanisms. The approach utilizes existing national health programs and mobile technology to bridge gaps in awareness and assessment.

Results

The CP model has the potential to substantially enhance drug safety monitoring, particularly in resource-limited settings, by improving ADR identification, awareness, and reporting at the community level.

Conclusion

Although challenges such as training of healthcare workers, integration of ADR reporting systems for wider coverage, and data validation need to be addressed, Community Pharmacovigilance® offers a transformative opportunity to improve health outcomes and establish a more inclusive, grassroots pharmacovigilance framework in India.